Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3217]

Study shows new drug effective in overcoming ibrutinib resistance in mantle cell lymphoma

Study shows new drug effective in overcoming ibrutinib resistance in mantle cell lymphoma

Diabetes linked to numerous cancers in large Chinese study

Diabetes linked to numerous cancers in large Chinese study

New drug effective in overcoming ibrutinib resistance in mantle cell lymphoma

New drug effective in overcoming ibrutinib resistance in mantle cell lymphoma

$Acalabrutinib increases progression-free survival relapsed or refractory chronic lymphocytic leukaemia$

Acalabrutinib increases progression-free survival relapsed or refractory chronic lymphocytic leukaemia

FDA approves ivosidenib as first-line treatment for AML with IDH1 mutation

FDA approves ivosidenib as first-line treatment for AML with IDH1 mutation

New cancer therapy target found in mitochondria for potential treatment of blood cancers

New cancer therapy target found in mitochondria for potential treatment of blood cancers

$Phase 1 interim results for anti-BCMA CAR T-cell therapy in relapse refractory multiple myeloma$

Phase 1 interim results for anti-BCMA CAR T-cell therapy in relapse refractory multiple myeloma

Researchers identify ways to predict and avoid radiotherapy side effects

Researchers identify ways to predict and avoid radiotherapy side effects

Radiotherapy after chemotherapy may improve survival for patients with advanced Hodgkin’s lymphoma

Radiotherapy after chemotherapy may improve survival for patients with advanced Hodgkin’s lymphoma

Researchers reveal key to targeting dormant cancer cells

Researchers reveal key to targeting dormant cancer cells

More from ecancer